DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Iwasaki T, Yoneda M, Inamori M. et al.
Sitagliptin as a novel treatment agent for non-alcoholic Fatty liver disease
patients with type 2 diabetes mellitus.
Hepatogastroenterology 2011;
58: 2103-2105
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.